Loss-of-function variants in NEK1 are associated with an increased risk of sporadic ALS in the Japanese population

Abstract

Loss-of-function (LoF) variants in NEK1 have recently been reported to be associated with amyotrophic lateral sclerosis (ALS). In this study, we investigated the association of NEK1 LoF variants with an increased risk of sporadic ALS (SALS) and the clinical characteristics of patients with SALS carrying LoF variants in a Japanese case series. Whole-exome sequencing analysis was performed for a series of 446 SALS patients in whom pathogenic variants in familial ALS-causative genes have not been identified and 1163 healthy control subjects in our Japanese series. We evaluated LoF variants, defined as nonsense, splice-site disrupting single-nucleotide variants (SNVs), or short insertion/deletion (indel) variants predicted to cause frameshifts in NEK1. We identified seven NEK1 LoF variants in patients with SALS (1.57%), whereas only one was identified in control subjects (0.086%) (P = 0.00073, Fisher’s exact test). This finding is consistent with those in recent reports from other regions in the world. In conclusion, we demonstrated that NEK1 LoF variants are also associated with an increased risk of SALS in the Japanese population.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197–206.

    Article  Google Scholar 

  2. 2.

    White MA, Sreedharan J. Amyotrophic lateral sclerosis: recent genetic highlights. Curr Opin Neurol. 2016;29:557–64.

    CAS  Article  Google Scholar 

  3. 3.

    Leblond CS, Kaneb HM, Dion PA, Rouleau GA. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol. 2014;262:91–101.

    CAS  Article  Google Scholar 

  4. 4.

    Chia R, Chiò A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94–102.

    CAS  Article  Google Scholar 

  5. 5.

    Naruse H, Ishiura H, Mitsui J, Date H, Takahashi Y, Matsukawa T, et al. Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation. Neurobiol Aging. 2018;61:255 e9–16.

    Article  Google Scholar 

  6. 6.

    Naruse H, Ishiura H, Mitsui J, Takahashi Y, Matsukawa T, Tanaka M, et al. Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS. J Neurol Neurosurg Psychiatry. 2019;90:537–42.

    Article  Google Scholar 

  7. 7.

    Takahashi Y, Seki N, Ishiura H, Mitsui J, Matsukawa T, Kishino A, et al. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. Arch Neurol. 2008;65:1326–32.

    Article  Google Scholar 

  8. 8.

    Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. 2013;93:900–5.

    CAS  Article  Google Scholar 

  9. 9.

    Naruse H, Iwata A, Takahashi Y, Ichihara K, Kamei S, Yamatoku M, et al. Familial amyotrophic lateral sclerosis with novel A4D SOD1 mutation with late age at onset and rapid progressive course. Neurol Clin Neurosci. 2013;1:45–7.

    CAS  Article  Google Scholar 

  10. 10.

    Segawa M, Hoshi A, Naruse H, Kuroda M, Bujo H, Ugawa Y. A patient with familial amyotrophic lateral sclerosis associated with a new valosin-containing protein (VCP) gene mutation. Rinsho shinkeigaku = Clin Neurol.2015;55:914–20.

    Article  Google Scholar 

  11. 11.

    Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, et al. C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol. 2012;69:1154–8.

    Article  Google Scholar 

  12. 12.

    Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.

    CAS  Article  Google Scholar 

  13. 13.

    Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.

    CAS  Article  Google Scholar 

  14. 14.

    Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436–41.

    CAS  Article  Google Scholar 

  15. 15.

    Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037–42.

    CAS  Article  Google Scholar 

  16. 16.

    Brenner D, Muller K, Wieland T, Weydt P, Bohm S, Lule D, et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139:e28.

    Article  Google Scholar 

  17. 17.

    Nguyen HP, Van Mossevelde S, Dillen L, De Bleecker JL, Moisse M, Van Damme P, et al. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging. 2018;61:255.e1–7.

    CAS  Article  Google Scholar 

  18. 18.

    Gratten J, Zhao Q, Benyamin B, Garton F, He J, Leo PJ, et al. Whole-exome sequencing in amyotrophic lateral sclerosis suggests NEK1 is a risk gene in Chinese. Genome Med. 2017;9:97.

    Article  Google Scholar 

  19. 19.

    Tsai YS, Lin KP, Jih KY, Tsai PC, Liao YC, Lee YC. Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant. Ann Clin Transl Neurol. 2020;7:965–71.

    CAS  Article  Google Scholar 

  20. 20.

    Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph lateral Scler Other Mot Neuron Disord. 2000;1:293–9.

    CAS  Article  Google Scholar 

  21. 21.

    Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank all the patients for participating in this study. We also thank all the neurologists who provided samples for this study. This work was supported by Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan (20FC1049) and Grant Number JP20ek0109491 from the Japan Agency for Medical Research and Development (AMED) to ST.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Shoji Tsuji.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Naruse, H., Ishiura, H., Mitsui, J. et al. Loss-of-function variants in NEK1 are associated with an increased risk of sporadic ALS in the Japanese population. J Hum Genet (2020). https://doi.org/10.1038/s10038-020-00830-9

Download citation

Search